Saltar al contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Lenguaje
Todos los Campos
Título
Autor
Materia
Número de Clasificación
ISBN/ISSN
Etiqueta
Buscar
Avanzado
A SYSTEMATIC REVIEW AND META-A...
Citar
Describir
Enviar este por Correo electrónico
Imprimir
Exportar Registro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enlace Permanente
A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (RCTS) OF EGFR-TARGETED MONOCLONAL ANTIBODY (MAB) THERAPY IN ADVANCED COLORECTAL CANCER (ACRC): IMPACT OF K-RAS STATUS
Detalles Bibliográficos
Autores principales:
Vale, C
,
Tierney, J
,
Meade, A
,
Fisher, D
,
Kaplan, R
,
Adams, R
,
Maughan, T
,
Parmar, M
Formato:
Journal article
Publicado:
2009
Existencias
Descripción
Ejemplares similares
Vista Equipo
Ejemplares similares
Impact of K-ras status on the effects of EGFR-targeted monoclonal antibody (MAb) therapy in advanced colorectal cancer (ACRC): A systematic review and meta-analysis of randomized controlled trials (RCTs)
por: Vale, C, et al.
Publicado: (2009)
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis.
por: Vale, C, et al.
Publicado: (2012)
Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis
por: Vale, C, et al.
Publicado: (2012)
THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
por: Maughan, T, et al.
Publicado: (2010)
Addition of cetuximab to oxaliplatin-based combination chemotherapy (CT) in patients with KRAS wild-type advanced colorectal cancer (ACRC): a randomised superiority trial (MRC COIN)
por: Maughan, T, et al.
Publicado: (2009)